Search research articles
Contact Us
Filters
Showing results (211-220 of 294) with videos related to
Page
of 30
Sort By:
Nature Reviews. Urology
|
May 22, 2023
Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease
Kyle M Rose, Heather L Huelster, Joshua J Meeks, et al.
European Urology
|
August 18, 2023
Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605
Peter C Black, Catherine M Tangen, Parminder Singh, et al.
Journal of the National Cancer Institute
|
January 15, 2009
Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer
Vitaly Margulis, Yair Lotan, Pierre I Karakiewicz, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not Matter
Ashish M Kamat, Niyati Lobo, Seth P Lerner, et al.
Clinical Chemistry
|
March 9, 2010
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers
Catharine M Sturgeon, Michael J Duffy, Barry R Hofmann, et al.
European Urology
|
May 17, 2023
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
Ibrahim Jubber, Sean Ong, Laura Bukavina, et al.
Cancer
|
March 5, 2013
Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group
Matthew D Galsky, Ryan Hendricks, Robert Svatek, et al.
BJU International
|
July 17, 2024
Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma
Abhishek Tripathi, Catherine M Tangen, Melissa Plets, et al.
The Journal of Urology
|
January 24, 2016
Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival
Friedrich-Carl von Rundstedt, Kimal Rajapakshe, Jing Ma, et al.
Clinical Genitourinary Cancer
|
December 12, 2012
Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer
Matthew D Galsky, Noah M Hahn, Thomas Powles, et al.
Page
of 30
Search research articles
Search
Showing results (211-220 of 294) with videos related to
Sort By:
Page
of 30
Nature Reviews. Urology
|
May 22, 2023
Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease
Kyle M Rose, Heather L Huelster, Joshua J Meeks, et al.
European Urology
|
August 18, 2023
Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605
Peter C Black, Catherine M Tangen, Parminder Singh, et al.
Journal of the National Cancer Institute
|
January 15, 2009
Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer
Vitaly Margulis, Yair Lotan, Pierre I Karakiewicz, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not Matter
Ashish M Kamat, Niyati Lobo, Seth P Lerner, et al.
Clinical Chemistry
|
March 9, 2010
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers
Catharine M Sturgeon, Michael J Duffy, Barry R Hofmann, et al.
European Urology
|
May 17, 2023
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
Ibrahim Jubber, Sean Ong, Laura Bukavina, et al.
Cancer
|
March 5, 2013
Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group
Matthew D Galsky, Ryan Hendricks, Robert Svatek, et al.
BJU International
|
July 17, 2024
Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma
Abhishek Tripathi, Catherine M Tangen, Melissa Plets, et al.
The Journal of Urology
|
January 24, 2016
Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival
Friedrich-Carl von Rundstedt, Kimal Rajapakshe, Jing Ma, et al.
Clinical Genitourinary Cancer
|
December 12, 2012
Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer
Matthew D Galsky, Noah M Hahn, Thomas Powles, et al.
Page
of 30